1,830
Participants
Start Date
June 30, 2011
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2016
TAXUS Element™ Paclitaxel-Eluting Stent System
Texus Element is the next generation Boston Scientific paclitexel-eluting coronary sten and received DCGI approval on April 13th, 2010.
Xience PRIME Everolimus-Eluting Stent System
The Everolimus-eluting stent manufactured and distributed by Abbott Vascular Santa Clara, CA, as Xience Prime.
Fortis Escorts Heart Institute, New Delhi
Collaborators (1)
Boston Scientific Corporation
INDUSTRY
Max Neeman Medical International Ltd.
UNKNOWN
Fortis Escorts Heart Institute
OTHER